Showing items 1 - 4 of 4

Your selections:

Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease

- Day, Fiona, Sridharan, Swetha, Oldmeadow, Christopher, Martin, Jarad, Johnson, Catherine, Quah, Gaik T., Mallesara, Girish, Kumar, Mahesh, Poulter, Amber-Louise, Morrison, Anthony, van der Westhuizen, Andre, Fraser, Allison

Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives

- De Boer, Richard, Beith, Jane, Zdenkowski, Nicholas, Bell, Richard, Chirgwin, Jacquie, Chua, Sue, Colosimo, Maree, Francis, Prudence, Green, Michael, Pittman, Ken, White, Michelle, Wilcken, Nicholas

Systemic treatment of HER2-positive metastatic breast cancer: a systematic review

- Wilcken, Nicholas, Zdenkowski, Nicholas, Chua, Sue, Chirgwin, Jacquie, Beith, Jane, Bell, Richard, White, Michelle, Snyder, Ray, Pittman, Ken, Mainwaring, Paul, Green, Michael, Francis, Prudence, De Boer, Richard, Colosimo, Maree

BRAF and NRAS mutational status are prognostically important in thick and locally advanced cutaneous melanoma

- Vilain, R., Braye, S. G., Ashman, L., Scott, R. J.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit